On Nov. 7, Teva Pharmaceutical (NASDAQ:TEVA) released third-quarter earnings for the period ended Sept. 30.
- Net sales increased 73.5% to $2.286 billion because of new product launches in the U.S. and merger synergies from acquisition of IVAX.
- One hundred and forty-four product applications await final FDA approval, giving TEVA plenty of future growth opportunities.
- EPS and net profit have increased by 85% and 127%, respectively, as improving margins boosted the bottom line.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Q3 2006 |
Q3 2005 |
Change | |
|---|---|---|---|
|
Sales |
$2,285.7 |
$1,317.3 |
73.5% |
|
Net Profit |
$606.4 |
$267.1 |
127% |
|
EPS |
$0.74 |
$0.40 |
85% |
|
Diluted Shares |
833.5 |
678.2 |
22.9% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q3 2006 |
Q3 2005 |
Change* | |
|---|---|---|---|
|
Gross Margin |
55.2% |
47% |
8.2 |
|
Operating Margin |
31.7% |
23.7% |
8.0 |
|
Net Margin |
26.5% |
20.3% |
6.3 |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets |
Q3 2006 |
Q3 2005 |
Change |
|---|---|---|---|
|
Cash + Invest. |
$2,100.0 |
$2054.9 |
2.2 |
|
Accounts Rec. |
No Data |
$1588.1 |
No Data |
|
Inventory |
No Data |
$1144.3 |
No Data |
|
Liabilities |
Q3 2006 |
Q3 2005 |
Change |
|---|---|---|---|
|
Accounts Payable |
No Data |
$1055.9 |
No Data |
|
Long-Term Debt |
$5,447.9 |
$1,621.4 |
236.0 |
Learn the ways of the balance sheet.
Cash Flow Highlights
|
YTD 2006 |
YTD 2005 |
Change | |
|---|---|---|---|
|
Cash From Ops. |
$793.0 |
$385.3 |
105.8 |
Find out why Fools always follow the money.
Related Companies:
- Mylan Laboratories (NYSE:MYL)
- Barr Pharmaceuticals (NYSE:BRL)
- Novo Nordisk (NYSE:NVO)
- Sanofi-Aventis (NYSE:SNY)
Related Foolishness:
- Nothing Generic About Teva's Performance
- The Diverging Fortunes of Forest and Teva
- Bristol-Myers and Sanofi Get Apotex to Stop
Get in the game with Motley Fool CAPS, our new community intelligence stock-picking service, and help make us smarter.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
